Windlas Biotech Experiences Revision in Its Stock Evaluation Amid Small-Cap Market Growth
The small-cap segment of the market is currently thriving, with a 0.88% rise today and a 0.21% increase over the past week, indicating strong investor confidence. Windlas Biotech stands out with a notable 7.43% return. The advance-decline ratio of 824 to 115 further underscores positive market sentiment. Additionally, several stocks, including Nahar Spinning and HLE Glascoat, have received favorable evaluation revisions, while technical call changes for Godavari Bioref. and Arkade suggest an optimistic outlook. This momentum in the small-cap market may present further investment opportunities ahead.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
